Skip to main content
Caplight Logo









Evidium

Evidium

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.evidium.com/

Last Round

Series A

Nov 10, 2025

Total Funding Raised

$22M

Company Overview

Evidium is a healthcare technology company that provides a neurosymbolic AI platform to transform clinical knowledge into computational models for care delivery and insurance environments.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Business Intelligence, InsurTech

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

medical AIhealthcare analyticsclinical decision supportclinical intelligencepredictive healthcareprobabilistic forecastingexplainable AIcost modelingclinical modelingrisk adjustmentSaaShealth informaticspayvider solutionspatient journey mappingblack-box AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Evidium Comparables

Compare Evidium with similar companies based on industry and business-model similarity.

Evidium comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Atropos Health
79%
Vera Health
77%
AvoMD
73%

Evidium Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 10, 2025

Key People

Founding team and executive leadership

Carl Bate

Founder & CEO

Founding Team

Sean Thomas

Chief Product Officer

Executive Team

Evidium Investors

Notable investors and investment history

Evidium investors
InvestorRounds
Health2047Series A
Interwoven VenturesSeries A
WGG PartnersSeries A
Mindset VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Developing a computational medical intelligence layer for healthcare.

Evidium Filings

Explore SEC and related filing metadata, where available.

Evidium filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Evidium's valuation, stock price, and market status.

Is Evidium a public or private company?

Evidium is a private company.

What is the current stock price of Evidium?

Evidium is a private company with no public stock price. No recent secondary market data is available.

How much is Evidium worth (valuation)?

Valuation information for Evidium is not publicly available.

Can I buy Evidium stock?

Evidium shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Evidium's last funding round?

Evidium's most recent funding round was Series A on November 10, 2025.

Who are the main investors in Evidium?

Key investors in Evidium include Health2047, WGG Partners.

Will Evidium IPO soon?

No public IPO plans have been announced for Evidium.

How can I track Evidium secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Evidium's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range30
Year Founded2021
Last FundingNov 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?